|
|
This
is the ESTRO Public Affairs newsletter: a monitoring service offered by
ESTRO to national societies of the radiation oncology area to keep
up-to-date with oncopolicy issues.
This issue of the newsletter is dedicated to "New European Leadership for Innovation, Health, and Cancer".
|
|
Content
Focus of the Month
New European Leadership for Innovation, Health, and Cancer
European Commission and European Parliament
Happening Across Europe at a Glance
Partnerships
News
- Parliamentary debate on the fight against cancer
- The need for AI ethics guidelines in radiology
- EU-wide Health Technology Assessment
- Focus on cancer prevention
|
|
|
New European leadership for Innovation, Health, and Cancer
European Commission and European Parliament
Following the 2019 European elections, a
new college of Commissioners is being nominated by the Member States to
lead the different Commission portfolios. To be officially appointed,
the Commissioner-designates must first go through the Parliamentary
hearing process, which took place from 30 October to 8 November.
However, three candidates did not pass their hearings, and the
Commission will therefore be unable to take office on 1 November as
planned. The delay will be of at least one month, the time for new
Commissioner-designates to go through the hearing process.
Commissioner-designate for the health portfolio , Stella Kyriakides, and Bulgarian Commissioner Mariya Gabriel, candidate for the portfolio on Innovation and Youth, successfully passed the hearing process.
Ms Gabriel's portfolio is focused on
bringing research and innovation into education, culture, and sports.
She expressed her commitment to Horizon Europe, pledging to hold
frequent meetings about its advancement as well as supporting an
increase in its budget from €94 billion to €120 billion. She also
highlighted the importance of funding programmes and the European
Innovation Council (EIC) in upholding Europe's role as a champion of
research and developing its role as a leader in innovation.
During her own hearing, Ms Kyriakides expressed her commitment to
advancing public health in Europe, using a "One Health" approach. She
will concentrate on tackling environmental health, healthy food, and
public health together as interrelated issues. Concerning the many
challenges currently awaiting the Health Commissioner at this time, Ms
Kyriakides presented her focus as being on access to healthcare, drug
shortages, and Health Technology Assessment (HTA). She also reiterated
her support for the cancer plan and promised to act on the use of
low-risk alternative solutions and reduction of use of pesticides and
endocrine disruptors.
At the European Parliament, the MEPs Against Cancer (MAC) interest group
renewed their leadership for the 2019-2024 legislature. The group will
now be co-chaired by Prof. Véronique Trillet-Lenoir (RE, France) and Mr.
Loucas Fourlas (EPP, Cyprus), supported by vice-chairs Mr. Rory Palmer
(S&D, United Kingdom) and Dr. Petra De Sutter (Greens/EFA, Belgium).
Secretarial support for the group, which now counts 137 members, will
be ensured by the European Cancer Leagues (ECL).
Read more about the MAC’s new leadership and their 2019 manifesto here and here.
|
|
Germany >> has committed, together with the Netherlands, to creating a European space facilitating the free movement of health data, while respecting the EU principle on data security. A Digital Supply Law is also being considered, which aims to facilitate and incentivize the use of e-Health.
The Netherlands >> launched the International Horizon Scanning Initiative with
8 other countries (DK, NO, PT, SE, CH, BE, IE, and LU). It will map new
drugs (and soon medical devices) entering the market to facilitate
international cooperation on price negotiations.
Belgium >> is investigating the restriction of market access for biosimilar producers by certain pharma companies.
|
|
Radiological Hazards Information for Safe use - Guidelines for Manufacturers
A
document instructing manufacturers on the development of the document
for undertakings in accordance with Article 78.2 of the Basic Safety
Standards (BSS) Directive was published by ESTRO and the European
Federation of Organisations For Medical Physics (EFOMP), in cooperation
with the Heads of the European Radiological Protection Competent
Authorities (HERCA). Read it here.
|
|
ECPC at ESTRO COURSE ON SKIN CANCER
On
8 November, the European Cancer Patient Coalition (ECPC) was invited as
a special guest to the ESTRO course on Multidisciplinary Management of
Melanoma Skin Care. They gave a lecture and added a patients’
perspective to the course.
|
|
ECCO Quality Cancer Care Week
The European CanCer Organisation (ECCO) led a week of awareness-raising and debate stimulation on the topic of quality cancer care:
what quality cancer care consists of and the policy needs required to
achieve it. On 5 November, a live event at the European Parliament was
organized on 5 November on “Quality Cancer Care: Data as a driver for
improvement”.
|
|
MAKE SENSE CAMPAIGN – ECPC and Head & neck Society
On Tuesday 5th November 2019, ECPC and the Make Sense campaign hosted an interactive meeting at the European Parliament to raise awareness of the challenges that face people living with head and neck cancer in Europe.
|
|
Parliamentary debate on the fight against cancer
Following
the proposal of the EPP Group to set up a special committee on cancer,
the European Parliament held a debate about it during the plenary
session in Brussels, on October 9. The resolution on a European Plan
against cancer - which would involve a holistic approach to tackling the
disease, from prevention to post-treatment care - will be voted on at a
future part-session.
Read more
|
|
The need for AI ethics guidelines in radiology
A joint European and North American multisociety statement
has been issued to highlight the need for clear guidelines on the
ethical use of AI-based systems in radiology, to avoid systemic errors
as more autonomous AI is adopted.
|
|
Focus on cancer prevention
The
Association of European Cancer Leagues (ECL) stated prevention as their
key priority for the EU Cancer Mission. They acknowledged that the
effects of prevention can take decades before materializing, but that
risk prevention strategies at the individual and national level
eventually help prevent up to 40% of cancers.
Read more
|
|
If you have any questions please contact Lara Fizaine
ESTRO Society Affairs & Policy Officer lfizaine@estro.org
|
|
|
|
|
|
|